Eruzun, H. 2026. Sclerosing cholangitis associated with dabrafenib–trametinib therapy: BRAF/MEK inhibitors should be considered. Journal of Gastrointestinal and Liver Diseases. 35, 1 (Mar. 2026), 136–137. DOI:https://doi.org/10.15403/jgld-6698.